These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36769850)

  • 21. Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis.
    Stevens TW; Gecse K; Turner JR; de Hertogh G; Rubin DT; D'Haens GR
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2333-2342. PubMed ID: 32801008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal Calprotectin is an Accurate Tool and Correlated to Seo Index in Prediction of Relapse in Iranian Patients With Ulcerative Colitis.
    Hosseini SV; Jafari P; Taghavi SA; Safarpour AR; Rezaianzadeh A; Moini M; Mehrabi M
    Iran Red Crescent Med J; 2015 Feb; 17(2):e22796. PubMed ID: 25793117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
    Dhaliwal A; Zeino Z; Tomkins C; Cheung M; Nwokolo C; Smith S; Harmston C; Arasaradnam RP
    Frontline Gastroenterol; 2015 Jan; 6(1):14-19. PubMed ID: 25580205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin.
    Cao Y; Dai Y; Zhang L; Wang D; Hu W; Yu Q; Wang X; Yu P; Liu W; Ping Y; Sun T; Sang Y; Liu Z; Chen Y; Tao Z
    J Inflamm Res; 2021; 14():6409-6419. PubMed ID: 34880643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity.
    Lee YW; Lee KM; Lee JM; Chung YY; Kim DB; Kim YJ; Chung WC; Paik CN
    Korean J Intern Med; 2019 Jan; 34(1):72-80. PubMed ID: 29347813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal calprotectin as an inflammatory biomarker in small bowel Crohn disease.
    Sousa MI; Dias E; Andrade P; Macedo G
    Porto Biomed J; 2024; 9(4):263. PubMed ID: 39132513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic.
    Moein S; Qujeq D; Vaghari Tabari M; Kashifard M; Hajian-Tilaki K
    Caspian J Intern Med; 2017; 8(3):178-182. PubMed ID: 28932369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy.
    Ferreiro-Iglesias R; Barreiro-de Acosta M; Otero Santiago M; Lorenzo Gonzalez A; Alonso de la Peña C; Benitez Estevez AJ; Dominguez-Muñoz JE
    J Clin Gastroenterol; 2016 Feb; 50(2):147-51. PubMed ID: 25811118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseases.
    Rottenstreich A; Mishael T; Granovsky SG; Koslowsky B; Schweistein H; Abitbol G; Goldin E; Shitrit AB
    Eur J Intern Med; 2020 Jul; 77():105-110. PubMed ID: 32197833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.
    Henderson P; Casey A; Lawrence SJ; Kennedy NA; Kingstone K; Rogers P; Gillett PM; Wilson DC
    Am J Gastroenterol; 2012 Jun; 107(6):941-9. PubMed ID: 22370604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-life utility and diagnostic accuracy of a home-performed fecal calprotectin test to predict endoscopic activity in patients with inflammatory bowel disease under maintenance treatment with adalimumab.
    Orfanoudaki E; Drygiannakis I; Theodoraki E; Foteinogiannopoulou K; Mantaka A; Koutroubakis IE
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e777-e782. PubMed ID: 34284415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low fecal calprotectin predicts clinical remission in Crohn's disease patients: the simple answer to a challenging question.
    Monteiro S; Dias de Castro F; Leite S; Moreira MJ; Cotter J
    Scand J Gastroenterol; 2019 Jan; 54(1):49-54. PubMed ID: 30663515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of fecal calprotectin for the early diagnosis of abdominal type of Henoch-Schonlein purpura in children.
    Teng X; Gao C; Sun M; Wu J
    Clin Rheumatol; 2018 Jun; 37(6):1667-1673. PubMed ID: 29018973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of fecal calprotectin in the diagnosis of neonatal necrotizing enterocolitis: a Meta analysis].
    Xie YQ; Ren CJ; Wang X; Xiang SW; Wang XX; Hao L
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Apr; 23(4):381-389. PubMed ID: 33840411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children.
    Ho SSC; Ross M; Keenan JI; Day AS
    Front Pediatr; 2020; 8():609279. PubMed ID: 33748035
    [No Abstract]   [Full Text] [Related]  

  • 36. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.
    Lozoya Angulo ME; de Las Heras Gómez I; Martinez Villanueva M; Noguera Velasco JA; Avilés Plaza F
    Gastroenterol Hepatol; 2017 Mar; 40(3):125-131. PubMed ID: 27260632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission.
    Diederen K; Hoekman DR; Leek A; Wolters VM; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Benninga MA; Kindermann A
    Aliment Pharmacol Ther; 2017 Apr; 45(7):951-960. PubMed ID: 28138990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study.
    Azramezani Kopi T; Shahrokh S; Mirzaei S; Asadzadeh Aghdaei H; Amini Kadijani A
    Gastroenterol Hepatol Bed Bench; 2019; 12(3):183-189. PubMed ID: 31528300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting.
    Mumolo MG; Bertani L; Ceccarelli L; Laino G; Di Fluri G; Albano E; Tapete G; Costa F
    World J Gastroenterol; 2018 Sep; 24(33):3681-3694. PubMed ID: 30197475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.